van der Lee, S., Conway, O., Jansen, I., Carrasquillo, M., Kleineidam, L., van den Akker, E., . . . Holstege, H. (2019). A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
Citación estilo Chicagovan der Lee, SJ, et al. A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer's Disease, Dementia With Lewy Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity. 2019.
Cita MLAvan der Lee, SJ, et al. A Nonsynonymous Mutation in PLCG2 Reduces the Risk of Alzheimer's Disease, Dementia With Lewy Bodies and Frontotemporal Dementia, and Increases the Likelihood of Longevity. 2019.
Precaución: Estas citas no son 100% exactas.